This model was confirmed to simulate PD-1/PD-L1 checkpoint blockade, providing a reliable in vitro model for the verification and clinical prediction of the therapeutic effects of relevant immunotherapy drugs for head and neck cancer (HNC). Here, CD274 is linked to head and neck cancer.